| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan
|
Rocha-Lima, Caio Max
|
|
2014
|
74 |
3 |
p. 479-486
|
artikel
|
| 2 |
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
|
Ikeda, Takaya
|
|
2014
|
74 |
3 |
p. 497-502
|
artikel
|
| 3 |
A phase 1 study to evaluate effect of food on veliparib pharmacokinetics and relative bioavailability in subjects with solid tumors
|
Mostafa, Nael M.
|
|
2014
|
74 |
3 |
p. 583-591
|
artikel
|
| 4 |
Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level
|
Gong, Anjing
|
|
2014
|
74 |
3 |
p. 531-538
|
artikel
|
| 5 |
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study
|
Zheng, Yulong
|
|
2014
|
74 |
3 |
p. 503-509
|
artikel
|
| 6 |
Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients
|
Koh, Youngil
|
|
2014
|
74 |
3 |
p. 653-657
|
artikel
|
| 7 |
Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer
|
Vijayvergia, Namrata
|
|
2014
|
74 |
3 |
p. 437-446
|
artikel
|
| 8 |
Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer
|
Choi, Moon Ki
|
|
2014
|
74 |
3 |
p. 521-529
|
artikel
|
| 9 |
Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx®)
|
Boers-Sonderen, Marye J.
|
|
2014
|
74 |
3 |
p. 457-463
|
artikel
|
| 10 |
Determining the mechanisms of lapatinib-induced diarrhoea using a rat model
|
Bowen, Joanne M.
|
|
2014
|
74 |
3 |
p. 617-627
|
artikel
|
| 11 |
Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
|
Chen, Nianhang
|
|
2014
|
74 |
3 |
p. 659-660
|
artikel
|
| 12 |
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer
|
Huang, Lynn YL
|
|
2014
|
74 |
3 |
p. 511-520
|
artikel
|
| 13 |
KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma
|
Zheng, Yun
|
|
2014
|
74 |
3 |
p. 487-495
|
artikel
|
| 14 |
Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi’s sarcoma (KS)
|
Bendle, M.
|
|
2014
|
74 |
3 |
p. 611-615
|
artikel
|
| 15 |
Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia
|
Kaefer, Aksana
|
|
2014
|
74 |
3 |
p. 593-602
|
artikel
|
| 16 |
Metronomics chemotherapy: time for computational decision support
|
Barbolosi, Dominique
|
|
2014
|
74 |
3 |
p. 647-652
|
artikel
|
| 17 |
Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice
|
Hassan, Memy H.
|
|
2014
|
74 |
3 |
p. 559-569
|
artikel
|
| 18 |
No pharmacokinetic alteration of docetaxel following coadministration of aprepitant 3 h before docetaxel infusion
|
Kaneta, Toshikado
|
|
2014
|
74 |
3 |
p. 539-547
|
artikel
|
| 19 |
Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
|
Galsky, Matthew D.
|
|
2014
|
74 |
3 |
p. 465-471
|
artikel
|
| 20 |
Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
|
Yang, Jianliang
|
|
2014
|
74 |
3 |
p. 637-646
|
artikel
|
| 21 |
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
|
Doi, Toshihiko
|
|
2014
|
74 |
3 |
p. 629-636
|
artikel
|
| 22 |
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
|
Lee, Keun-Wook
|
|
2014
|
74 |
3 |
p. 447-455
|
artikel
|
| 23 |
Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia
|
Chalret du Rieu, Quentin
|
|
2014
|
74 |
3 |
p. 571-582
|
artikel
|
| 24 |
RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level
|
Gong, Anjing
|
|
|
74 |
3 |
p. 531-538
|
artikel
|
| 25 |
Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy
|
Wen, Chengtao
|
|
2014
|
74 |
3 |
p. 473-478
|
artikel
|
| 26 |
Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404
|
Shien, Tadahiko
|
|
2014
|
74 |
3 |
p. 603-609
|
artikel
|
| 27 |
Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide
|
Stedingk, Hans von
|
|
2014
|
74 |
3 |
p. 549-558
|
artikel
|
Tijdschrift beschrijving